Pembelian

ATHX Update

55
Oscillators indicate a decent risk/reward entry now on ATHX (with tight stop). No chart reversal pattern apparent yet. High call interest and several pipeline catalysts set the stage early into next year. As a Plus ++ expect heighten interest in small tech bio regen medicine stocks as a new bio sector ETF during January kicks-off with PRMF's IPO. wrhambrecht.com/poliwogg-regenerative-medicine-fund/ I'd expect this IPO to have a positive affect on many of the regeneration medicine tickers.

Pernyataan Penyangkalan

Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.